3SBio Inc. to Present at the UBS Warburg Global Life Sciences Conference

SHENYANG, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 25, 2007 at 10:30 AM EST.

The presentation will be webcast live and can be accessed on the Events section of the investors page of the 3SBio website at http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65. A replay of the presentation and accompanying slides will be available on the 3SBio website until October 27, 2007.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com.

For more information, please contact: Investor Contact: Clara Mak, CFO 3SBio Inc. Phone: +86-24-2581-1820 Investor Relations (HK): Ruby Yim Taylor Rafferty Phone: +852-3196-3712 Investor Relations (US): Mahmoud Siddig Taylor Rafferty Phone: +1-212-889-4350 Media Contact: John Dooley Taylor Rafferty Phone: +1-212-889-4350

3SBio Inc.

CONTACT: Investors: Clara Mak, CFO of 3SBio Inc. at +86-24-2581-1820;Investor Relations (HK): Ruby Yim of Taylor Rafferty at +852-3196-3712;Investor Relations (US): Mahmoud Siddig of Taylor Rafferty at+1-212-889-4350; Media: John Dooley of Taylor Rafferty at +1-212-889-4350

Back to news